Related Experiment Video
Updated: Aug 16, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Plasma exosomal miR-199a-3p downregulates cell proliferation and migration in Hirschsprung's disease by targeting
Yu Daiyue1, Yang Yang1, Huang Zhaorong1
1Department of Pediatric Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Background:
Plasma exosomal microRNAs have been suggested to be potential biomarkers of disease. However, the exosomal microRNAs in Hirschsprung's disease (HSCR) are still unclear. In this study, we analyzed the miRNA profiles of HSCR and elucidated the mechanism of the selected miR-199a-3p in the development of HSCR.
Methods:
Plasma exosomes were isolated, and exosomal miRNA high-throughput sequencing was performed to obtain differentially expressed miRNAs. CCK-8 and Transwell assay were used to determine the function of the most differentially expressed miRNA, which was confirmed in tissue specimen. Thereafter, target genes of the selected miRNAs were predicted by the databases. Gene Ontology (GO) analysis, Kyoto Encyclopedia of Genes Genomes (KEGG) analysis, and protein-protein interaction network (PPI) construction of possible target genes were used to perform enrichment analysis and interaction. Finally, the PCR, Western blot and recovery experiment were used to confirm the function of target gene, mammalian target of rapamycin (mTOR), in vitro.
Results:
The expression of miR-199a-3p was upregulated in plasma exosomes and diseased colonic tissues of patients with HSCR. In vitro, miR-199a-3p can inhibit cell proliferation and migration. Bioinformatic analysis suggested that mTOR might be a potential target of miR-199a-3p in HSCR. mTOR was discovered to be downregulated by miR-199a-3p in vitro. The negative connection between mTOR and miR-199a-3p was confirmed in tissue samples. mTOR can partially reverse the effect of miR-199a-3p on cell proliferation and migration function in vitro.
Conclusions:
miR-199a-3p suppresses cell growth and motility, partially by targeting mTOR. Plasma exosomal miR-199a-3p, a diagnostic marker, is crucial for the development of HSCR.
Insights
Plasma exosomal miR-199a-3p is upregulated in Hirschsprung's disease (HSCR) and inhibits cell growth by targeting mTOR. This microRNA is a potential diagnostic marker and therapeutic target for HSCR.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Plasma exosomal microRNAs are potential disease biomarkers.
- Exosomal microRNAs in Hirschsprung's disease (HSCR) remain largely uncharacterized.
- This study investigates miR-199a-3p in HSCR pathogenesis.
Purpose of the Study:
- To analyze miRNA profiles in HSCR.
- To elucidate the mechanism of miR-199a-3p in HSCR development.
- To identify potential diagnostic biomarkers for HSCR.
Main Methods:
- Plasma exosome isolation and miRNA sequencing.
- Cell proliferation and migration assays (CCK-8, Transwell).
- Bioinformatic analysis (GO, KEGG, PPI) and target validation (PCR, Western blot) for miR-199a-3p and mTOR.
Main Results:
- miR-199a-3p was upregulated in plasma exosomes and HSCR tissues.
- miR-199a-3p inhibited cell proliferation and migration in vitro.
- mTOR was identified as a target of miR-199a-3p, showing downregulation and a negative correlation in HSCR tissues. mTOR partially reversed miR-199a-3p's effects.
Conclusions:
- miR-199a-3p suppresses cell growth and motility by targeting mTOR.
- Plasma exosomal miR-199a-3p is a crucial diagnostic marker for HSCR.
- miR-199a-3p represents a potential therapeutic target for HSCR.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
MicroRNAs